Advanced Pharmacoeconomics
More than ever, Pharmacoeconomics has become an important subject within the Healthcare Industry. Various payors are requiring pharmacoeconomic studies to determine whether they will be listing new products on formularies. Whether you are a Sales Representative, a specialist in Access or you are working in Regulatory Affairs or Public Affairs, Pharmacoeconomics is playing an ever increasing importance to you and your customers. Advanced Pharmacoeconomics is a stand-alone course that builds on CCPE’s Basic Pharmacoeconomics course. The Advanced Pharmacoeconomics course provides a more in-depth review of the principles for those who aspire to a greater knowledge in how pharmacoeconomic studies are conducted, interpreted and used to make policy and clinical decisions. As such, Basic Pharmacoeconomics is a mandatory pre-requisite for CCPE’s Advanced Pharmacoeconomics course. Students who registered in CCPE’s Pharmacoeconomics course up to November 2016 are eligible to separately take Basic Pharmacoeconomics and Advanced Pharmacoeconomics as a way to re-train in this area. Two additional courses will appear on your CCPE transcript.
LEARNING OBJECTIVES
After completing the course, students will be able to:
- Discuss advanced concepts in cost-effectiveness and cost-utility analyses
- Draw decision trees and perform the calculations involved in decision analysis
- Discuss Markov Modeling
- Describe how to create, read and assess pharmacoeconomic studies
EXAM INFORMATION
- 50 multiple choice questions
Course Features
- Suggested Hours of Study 33
- Quizzes 0
- Suggested Hours of Study 15 hrs
- Course Completion 3 months
- Course Format Paper w/ PDF
- RxTx No
- Language English
- Pages 155 pages
- C.E. Credits What is this? 2.5
- Orientation Package
Exam Details
- # of Questions 50
- Time Limit 75 min
- Passing Grade 60%
Pricing
- Price $1,112.00
- Corporate Member $556.00
- Corporate Non-Member $2,780.00
-
CHAPTER 1: Introduction to Advanced Pharmacoeconomics and Review of Basic Pharmacoeconomics
- Describe the basics of measuring & estimating health care costs and outcomes
- Discuss the difference in information provided between pharmacoeconomic methods: Cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis
- Discuss the basis of acquiring pharmacoeconomic data
- Prepare for a greater understanding of pharmacoeconomic method through seeing them applied in decision-making and real-life practice
-
CHAPTER 2: Advanced Concepts in Cost-Effectiveness and Cost-Utility Analyses
- Discuss the presence of uncertainty when conducting pharmacoeconomic studies, and methods to account for uncertainty
- Understand the purpose and be able to interpret a cost-effectiveness acceptability curve
- Explain the terms efficiency frontier and extended dominance
- Define health-related quality of life (HRQoL) and explain its significance in pharmacoeconomic studies
- List the two different measures to evaluate HRQoL, and provide examples of these measures
-
CHAPTER 3: Decision Analysis
-
CHAPTER 4: Markov Modelling
-
CHAPTER 5: Drug Approval Process in Canada
- Describe the process of drug approval through Health Canada from molecule discovery to approval
- Discuss the purpose of, and differences between, pre-clinical trials and clinical trials in their different phases
- Describe the significance of attaining a Notice of Compliance for a drug
- Describe the function of the Patented Medicines Prices Review Board
- Describe the process of the Common Drug Review and CADTH
- Discuss the considerations third party decision makers use when making policy decisions about paying for medications
- Describe how Pharmacoeconomics may have an impact on clinical practice
-
CHAPTER 6: Critical Assessment of Pharmacoeconomic Studies
-
CHAPTER 7: Creating a Pharmacoeconomic Study
